Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 253, Issue 1, 2003, Pages 9-15

  Ende, Gabriele ^a   Braus, Dieter F ^a   Walter, Sigrid ^a   Weber Fahr, Wolfgang ^a   Henn, Fritz A ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Basal ganglia; Hippocampus; N acetylaspartate; Putamen; Schizophrenia

Indexed keywords

CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CHOLINE; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; ARTICLE; BASAL GANGLION; BRAIN METABOLISM; CLINICAL ARTICLE; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MENTAL DISEASE; NEURORADIOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOSIS; PUTAMEN; SCHIZOPHRENIA; THALAMUS; CASE CONTROL STUDY; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; ASPARTIC ACID; BASAL GANGLIA; CASE-CONTROL STUDIES; CHOLINE; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOCREATINE; PUTAMEN; SCHIZOPHRENIA; THALAMUS;

EID: 0042229301     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-003-0398-5     Document Type: Article

References (32)

1. Andreasen NC, Nopoulos P, O'Leary DS, et al. (1999) Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 46(7):908-920
2. Bertolino A, Callicott JH, Elman I, et al. (1998a) Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 43(9):641-648
3. Bertolino A, Callicott JH, Nawroz S, et al. (1998b) Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology 18(1):1-9
4. Bertolino A, Nawroz S, Mattay VS, et al. (1996) Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 153(12):1554-1563
5. Block W, Bayer TA, Tepest R, et al. (2000) Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci Lett 289(2):147-151
6. Buchsbaum MS, Yang S, Hazlett E, et al. (1997) Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr Res 27(1):45-53
7. Bustillo JR, Lauriello J, Rowland LM, et al. (2001) Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. Psychiatry Research. Neuroimaging 107:135-149
8. Corson PW, Nopoulos P, Miller DD, et al. (1999) Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156(8): 1200-1204
9. Deicken RF, Johnson C, Eliaz Y, et al. (2000) Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. Am J Psychiatry 157(4):644-647
10. Deicken RF, Pegues M, Amend D (1999) Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia. Schizophr Res 37(3):217-223
11. Deicken RF, Zhou L, Schuff N, et al. (1998) Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry 43(7):483-488
12. Delamillieure P, Constans J, Fernandez J, et al. (2000) Proton magnetic resonance spectroscopy (1H-MRS) of the thalamus in schizophrenia. Eur Psychiatry 15(8):489-491
13. Elkashef AM, Buchanan RW, Gellad F, et al. (1994) Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. Am J Psychiatry 151(5):752-755
14. Ende G, Braus DF, Walter S, et al. (2001) Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study. Am J Psychiatry 158(8):1314-1316
15. Ende G, Braus DF, Walter S, et al. (2000) Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 41(3): 389-395
16. Fujimoto T, Nakano T, Takano T, et al. (1996) Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Biol Psychiatry 40(1):14-18
17. Harrison PJ (1999) Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors. Br J Psychiatry Suppl (38):12-22
18. Hazlett EA, Buchsbaum MS, Byne W, et al. (1999) Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 156(8):1190-1199
19. Heimberg C, Komoroski RA, Lawson WB, et al. (1998) Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res 83(2):105-115
20. Hokama H, Shenton ME, Nestor PG, et al. (1995) Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Res 61(4):209-229
21. Maier M, Ron MA (1996) Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 22(1):5-17
22. Maudsley AA, Matson GB, Hugg JW, Weiner MW (1994) Reduced phase encoding in spectroscopic imaging. Magn Reson Med 31(6):645-51
23. McCarley RW, Wible CG, Frumin M, et al. (1999) MRI anatomy of schizophrenia. Biol Psychiatry 45(9):1099-1119
24. Nasrallah HA, Skinner TE, Schmalbrock P, et al. (1994) Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br J Psychiatry 165: 481-485
25. Obergriesser T, Ende G, Braus DF, Henn FA (2001) Hippocampal 1H-MRSI in ecstasy users. Eur Arch Psychiatry Clin Neurosci 251(3):114-116
26. Okugawa G, Sedvall GC, Agartz I (2002) Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci 252(3):120-123
27. Omori M, Murata T, Kimura H, et al. (2000) Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res 98(3):155-162
28. Sharma R, Venkatasubramanian PN, Barany M, et al. (1992) Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res 8(1):43-49
29. Shioiri T, Hamakawa H, Kato T, et al. (1996) Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report. Schizophr Res 22(1):19-26
30. Torrey EF (2002) Studies of individuals with schizophrenia never treated with antipsychotic medications: a review. Schizophr Res 58(2-3):101-115
31. Weinberger DR (1999) Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 45(4):395-402
32. Wright IC, Rabe-Hesketh S, Woodruff PW, et al. (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157(1):16-25